MicroPort Scientific Corporation announced on October 4th, 2021, through its critical care subsidiary, MicroPort Surgical B.V., has acquired 100% of the equity held by existing shareholders of Hemovent GmbH for a total cash consideration of up to €123 million.
October 4, 2021
· 2 min read